Article
B cell exhaustion associates with poor response to Bacillus Calmette-Guérin immunotherapy in patients with bladder cancer
2026-04-03
Abstract excerpt
The majority of patients treated with Bacillus Calmette–Guérin (BCG) immunotherapy, for non-muscle invasive bladder cancer (NMIBC), experience early recurrence due to pre-existing mucosal immune dysfunction. Since B cell are mucosal immune sentinels, we characterized the systemic and local B cell responses in 45 patients with NMIBC. Expansion of circulating atypical B cells (ABCs) following repeated BCG instillati...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d7ca4fa3-c3f5-5502-8e93-67371a8baaef
- DOI
- 10.64898/2026.04.01.715137
